New tool aims to boost IUD use for cancer prevention
NCT ID NCT07382583
First seen Feb 03, 2026 · Last updated Jun 20, 2026 · Updated 22 times
Summary
This study is creating a shared decision-making tool to help women and their doctors talk about using a levonorgestrel IUD to prevent endometrial cancer. Researchers will survey 270 women, both with and without the condition, to understand their preferences. The goal is to make it easier for women at risk to consider this prevention option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Harris Health System (LBJ)
RECRUITINGHouston, Texas, 77026, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
levonorgestrel-releasing intrauterine system (LNG-IUS)
What this could lead to
If successful, this tool could help more women at risk choose an IUD that may lower their chance of developing endometrial cancer.
What could go wrong
This is an early-stage study developing a decision aid, not testing the IUD itself. It may not change actual cancer rates or be widely adopted.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.